Sökning: onr:"swepub:oai:lup.lub.lu.se:b4b73ba9-b0f5-4666-8388-45a575fadb4b" >
Mesenchymal stem/st...
Mesenchymal stem/stromal cell-based therapies for severe viral pneumonia: therapeutic potential and challenges
-
- Masterson, C. H. (författare)
- National University of Ireland Galway
-
- Ceccato, A. (författare)
- CIBER Enfermedades Respiratorias (CIBERES)
-
- Artigas, A. (författare)
- CIBER Enfermedades Respiratorias (CIBERES)
-
visa fler...
-
- dos Santos, C. (författare)
- University of Toronto
-
- Rocco, P. R. (författare)
- Federal University of Rio de Janeiro
-
- Rolandsson Enes, Sara (författare)
- Lund University,Lunds universitet,Lungbiologi,Forskargrupper vid Lunds universitet,Lung Biology,Lund University Research Groups
-
- Weiss, D. J. (författare)
- University of Vermont Medical Center (UVM)
-
- McAuley, D. (författare)
- Royal Victoria Hospital, Belfast
-
- Matthay, M. A. (författare)
- University of California, San Francisco
-
- English, K. (författare)
- Maynooth University
-
- Curley, G. F. (författare)
- Royal College of Surgeons in Ireland
-
- Laffey, J. G. (författare)
- National University of Ireland Galway
-
visa färre...
-
(creator_code:org_t)
- 2021-12-31
- 2021
- Engelska.
-
Ingår i: Intensive Care Medicine Experimental. - : Springer Science and Business Media LLC. - 2197-425X. ; 9:61, s. 1-21
- Relaterad länk:
-
http://dx.doi.org/10... (free)
-
visa fler...
-
https://icm-experime...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Severe viral pneumonia is a significant cause of morbidity and mortality globally, whether due to outbreaks of endemic viruses, periodic viral epidemics, or the rarer but devastating global viral pandemics. While limited anti-viral therapies exist, there is a paucity of direct therapies to directly attenuate viral pneumonia-induced lung injury, and management therefore remains largely supportive. Mesenchymal stromal/stem cells (MSCs) are receiving considerable attention as a cytotherapeutic for viral pneumonia. Several properties of MSCs position them as a promising therapeutic strategy for viral pneumonia-induced lung injury as demonstrated in pre-clinical studies in relevant models. More recently, early phase clinical studies have demonstrated a reassuring safety profile of these cells. These investigations have taken on an added importance and urgency during the COVID-19 pandemic, with multiple trials in progress across the globe. In parallel with clinical translation, strategies are being investigated to enhance the therapeutic potential of these cells in vivo, with different MSC tissue sources, specific cellular products including cell-free options, and strategies to ‘licence’ or ‘pre-activate’ these cells, all being explored. This review will assess the therapeutic potential of MSC-based therapies for severe viral pneumonia. It will describe the aetiology and epidemiology of severe viral pneumonia, describe current therapeutic approaches, and examine the data suggesting therapeutic potential of MSCs for severe viral pneumonia in pre-clinical and clinical studies. The challenges and opportunities for MSC-based therapies will then be considered.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Lungmedicin och allergi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Respiratory Medicine and Allergy (hsv//eng)
Publikations- och innehållstyp
- for (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Masterson, C. H.
-
Ceccato, A.
-
Artigas, A.
-
dos Santos, C.
-
Rocco, P. R.
-
Rolandsson Enes, ...
-
visa fler...
-
Weiss, D. J.
-
McAuley, D.
-
Matthay, M. A.
-
English, K.
-
Curley, G. F.
-
Laffey, J. G.
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Lungmedicin och ...
- Artiklar i publikationen
-
Intensive Care M ...
- Av lärosätet
-
Lunds universitet